Arvinas, Inc. (ARVN) vs Oculis Holding AG (OCS)
- Arvinas, Inc. ARVN 7.14 −4.16%
- Oculis Holding AG OCS 7.35 −6.73%
Arvinas, Inc. and Oculis Holding AG are both Biotechnology companies. Arvinas, Inc. and Oculis Holding AG are of similar size ($514.9M and $499.6M). Oculis Holding AG has negative trailing earnings, so its P/E is not meaningful; Arvinas, Inc. trades at 57.3×. Oculis Holding AG grew revenue faster over the last twelve months: 65.8% against −15.1%. Arvinas, Inc. has the higher net margin (2.94% vs −6,870.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Arvinas, Inc. leads on 11 and Oculis Holding AG on 5.
Valuation
Profitability
| Metric | ARVN | OCS | Biotechnology median |
|---|---|---|---|
| Gross margin | 97.16% | 100.00% | 65.16% |
| Operating margin | (5.72%) | (7,383.66%) | 0.00% |
| Net margin | 2.94% | (6,870.05%) | 0.00% |
| Free cash flow margin | (65.93%) | (5,525.64%) | 0.00% |
| Return on equity | 1.59% | (44.87%) | (56.66%) |
| Return on assets | 1.17% | (37.69%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack